Clinical Trial Update: Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patient Undergoing Laparoscopic Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating bupivacaine liposomal injection (Exparel) for postoperative analgesia in patients undergoing laparoscopic bariatric sur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Postoperative
• Postoperative Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Pain, Postoperative | Phase 4 | Status: COMPLETED | Results posted: 2020-03-03